A multi-layer absorbent product is provided that includes a first layer that is either liquid permeable or liquid impermeable and a layer of a treated nonwoven, woven or knitted textile material or a treated textured plastic yarn. The layer of textured plastic yarn or of nonwoven, woven or knitted textile material has uniformly spaced deposits of a natural polymer crosslinked to a synthetic polymer in the absence of non-polymeric crosslinking agent, where each of the deposits is a continuous polymer network that covers the textile or plastic underneath the deposit and interpenetrates the network of textile fibers or of plastic pores acting as a scaffold to interconnect the polymer network with the fiber network or with the network of plastic pore walls. A process for preparing the layer of textile material or of textured plastic yarn with uniformly spaced deposits is also provided.

A biodegradable resin composition containing a resin and a protein, the resin being contained in an amount of 40 to 99.9% by mass in the resin composition, the resin containing a polyester-based resin, the polyester-based resin having three or more structural units, at least one of the structural units being a succinic acid unit, an azelaic acid unit, a sebacic acid unit, or a brassylic acid unit. The biodegradable resin composition can increase the speed of biodegradation and the percentage of degradation of a polyester-based resin in the sea and has good moldability. A molded article of the biodegradable resin composition. A method of biodegrading a polyester-based resin, by biodegrading the polyester-based resin in sea water in the presence of a protein.

A biodegradable resin composition containing a resin and a protein, the resin being contained in an amount of 40 to 99.9% by mass in the resin composition, the resin containing a polyester-based resin, the polyester-based resin having three or more structural units, at least one of the structural units being a succinic acid unit, an azelaic acid unit, a sebacic acid unit, or a brassylic acid unit. The biodegradable resin composition can increase the speed of biodegradation and the percentage of degradation of a polyester-based resin in the sea and has good moldability. A molded article of the biodegradable resin composition. A method of biodegrading a polyester-based resin, by biodegrading the polyester-based resin in sea water in the presence of a protein.

A biodegradable resin composition containing a resin and a protein, the resin being contained in an amount of 40 to 99.9% by mass in the resin composition, the resin containing a polyester-based resin, the polyester-based resin having three or more structural units, at least one of the structural units being a succinic acid unit, an azelaic acid unit, a sebacic acid unit, or a brassylic acid unit. The biodegradable resin composition can increase the speed of biodegradation and the percentage of degradation of a polyester-based resin in the sea and has good moldability. A molded article of the biodegradable resin composition. A method of biodegrading a polyester-based resin, by biodegrading the polyester-based resin in sea water in the presence of a protein.

A system and method for tissue fabrication involves the use of charge manipulation between two biomaterials to generate a shrinking response, which effectively enhances the resolution of bioprinted hydrogels. The charge manipulation can be utilized to generate tissue engineered thin, membranous tissues, such as the periosteum, which is approximately one hundred microns in thickness. Thin membranous tissues in the body also have relatively complex anatomies containing multiple cell populations, and no prior strategies allow for the effective and biomimetic generation of these tissues, which can have significant impact on tissue regeneration.

A system and method for tissue fabrication involves the use of charge manipulation between two biomaterials to generate a shrinking response, which effectively enhances the resolution of bioprinted hydrogels. The charge manipulation can be utilized to generate tissue engineered thin, membranous tissues, such as the periosteum, which is approximately one hundred microns in thickness. Thin membranous tissues in the body also have relatively complex anatomies containing multiple cell populations, and no prior strategies allow for the effective and biomimetic generation of these tissues, which can have significant impact on tissue regeneration.

A method for synthesizing a nanohybrid comprising forming a polymer solution by dissolving carboxymethyl chitosan and gelatin in a 2-(N-Morpholino)ethanesulfonic acid (MES) buffer, forming a first solution by adding (3-Glycidyloxypropyl)trimethoxysilane (GPTMS) to the polymer solution, forming a second solution by adding an acid-hydrolyzed tetraethyl orthosilicate (TEOS) solution to the first solution, forming a third solution by adding a calcium chloride (CaCl.sub.2) solution to the second solution, forming a fourth solution by mixing the third solution with a solution of 1 ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS), forming a frozen nanohybrid, and thawing the frozen nanohybrid.

A method for synthesizing a nanohybrid comprising forming a polymer solution by dissolving carboxymethyl chitosan and gelatin in a 2-(N-Morpholino)ethanesulfonic acid (MES) buffer, forming a first solution by adding (3-Glycidyloxypropyl)trimethoxysilane (GPTMS) to the polymer solution, forming a second solution by adding an acid-hydrolyzed tetraethyl orthosilicate (TEOS) solution to the first solution, forming a third solution by adding a calcium chloride (CaCl.sub.2) solution to the second solution, forming a fourth solution by mixing the third solution with a solution of 1 ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS), forming a frozen nanohybrid, and thawing the frozen nanohybrid.

A method for synthesizing a nanohybrid comprising forming a polymer solution by dissolving carboxymethyl chitosan and gelatin in a 2-(N-Morpholino)ethanesulfonic acid (MES) buffer, forming a first solution by adding (3-Glycidyloxypropyl)trimethoxysilane (GPTMS) to the polymer solution, forming a second solution by adding an acid-hydrolyzed tetraethyl orthosilicate (TEOS) solution to the first solution, forming a third solution by adding a calcium chloride (CaCl.sub.2) solution to the second solution, forming a fourth solution by mixing the third solution with a solution of 1 ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS), forming a frozen nanohybrid, and thawing the frozen nanohybrid.

Described are compositions and methods for cartilage replacement. Also described are collagen scaffolds comprising the composition described herein.